Sarepta Therapeutics, Inc. (SRPT): Price and Financial Metrics
Sarepta Therapeutics, Inc. (SRPT)
Today's Latest Price: $135.91 USD
Updated Oct 30 4:15pm
Add SRPT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
SRPT Stock Summary
- With a one year PEG ratio of 344.67, Sarepta Therapeutics Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 90.36% of US stocks.
- Price to trailing twelve month operating cash flow for SRPT is currently 36.92, higher than 90.51% of US stocks with positive operating cash flow.
- With a price/sales ratio of 23.7, Sarepta Therapeutics Inc has a higher such ratio than 93.36% of stocks in our set.
- Stocks that are quantitatively similar to SRPT, based on their financial statements, market capitalization, and price volatility, are XLRN, FOLD, BBIO, SGMO, and PTCT.
- SRPT's SEC filings can be seen here. And to visit Sarepta Therapeutics Inc's official web site, go to www.sarepta.com.
SRPT Stock Price Chart Interactive Chart >
SRPT Price/Volume Stats
| Current price | $135.91 | 52-week high | $175.00 |
| Prev. close | $141.49 | 52-week low | $78.06 |
| Day low | $134.14 | Volume | 723,100 |
| Day high | $141.53 | Avg. volume | 822,308 |
| 50-day MA | $140.81 | Dividend yield | N/A |
| 200-day MA | $135.29 | Market Cap | 10.67B |
Sarepta Therapeutics, Inc. (SRPT) Company Bio
Sarepta Therapeutics is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. The company was founded in 1980 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...